MCDONNELL MICHAEL R 4
4 · BIOGEN INC. · Filed Feb 10, 2025
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
McDonnell Michael R.
EVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-02-07$141.35/sh−786$111,101→ 20,955 total - Exercise/Conversion
Common Stock
2025-02-07+2,335→ 21,741 total - Tax Payment
Common Stock
2025-02-07$141.35/sh−716$101,207→ 22,455 total - Exercise/Conversion
Restricted Stock Unit
2025-02-07−2,216→ 4,434 totalExercise: $0.00Exp: 2027-02-07→ Common Stock (2,216 underlying) - Exercise/Conversion
Common Stock
2025-02-07+2,216→ 23,171 total - Exercise/Conversion
Restricted Stock Unit
2025-02-07−2,335→ 2,335 totalExercise: $0.00Exp: 2026-02-08→ Common Stock (2,335 underlying)
Footnotes (2)
- [F1]The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023.
- [F2]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.